PROMETHEUS BIOSCIENCES, INC. Financing Cash Flow
PROMETHEUS BIOSCIENCES, INC. reported Financing Cash Flow of $52.80 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2023-05-09
- PROMETHEUS BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2023-03-31 was $52.80M, a 42826.02% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was $475.33M, a 94025.54% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was $72.11M.
- PROMETHEUS BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2022-06-30 was $14.63M.
- PROMETHEUS BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2022 was $562.20M, a 110.02% increase from fiscal 2021.
- PROMETHEUS BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2021 was $267.69M, a 235.10% increase from fiscal 2020.
- PROMETHEUS BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2020 was $79.89M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2023-03-31 | $52.80M 10-Q · filed 2023-05-09 | $528.13M derived: sum of 2 quarters · filed 2023-05-09 | $600.24M derived: sum of 3 quarters · filed 2023-05-09 | $614.88M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | $475.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $547.44M derived: sum of 2 quarters · filed 2023-02-28 | $562.08M derived: sum of 3 quarters · filed 2023-02-28 | $562.20M 10-K · filed 2023-02-28 |
| 2022-09-30 | $72.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $86.75M derived: sum of 2 quarters · filed 2022-11-09 | $86.87M 10-Q · filed 2022-11-09 | $87.37M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-06-30 | $14.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $14.76M 10-Q · filed 2022-08-11 | $15.26M derived: sum of 3 quarters · filed 2023-05-09 | $7.33M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-03-31 | $123.00K 10-Q · filed 2023-05-09 | $628.00K derived: sum of 2 quarters · filed 2023-05-09 | -$7.30M derived: sum of 3 quarters · filed 2023-05-09 | -$8.51M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $505.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$7.42M derived: sum of 2 quarters · filed 2023-02-28 | -$8.63M derived: sum of 3 quarters · filed 2023-02-28 | $267.69M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$7.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$9.13M derived: sum of 2 quarters · filed 2022-11-09 | $267.19M 10-Q · filed 2022-11-09 | $312.70M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $275.12M 10-Q · filed 2022-08-11 | $320.63M derived: sum of 3 quarters · filed 2023-02-28 | $319.62M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $276.32M 10-Q · filed 2022-05-12 | $321.84M derived: sum of 2 quarters · filed 2023-02-28 | $320.82M derived: sum of 3 quarters · filed 2023-02-28 | $320.90M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $45.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $44.50M derived: sum of 2 quarters · filed 2023-02-28 | $44.58M derived: sum of 3 quarters · filed 2023-02-28 | $79.89M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$937.00K derived: sum of 2 quarters · filed 2021-11-12 | $34.37M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $35.39M 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $35.31M 10-Q · filed 2021-05-13 |